Fatigue

Advertisement

cGxPJobs Banner

Khondrion Doses First Patient in Phase 3 KHENERFIN Study

NIJMEGEN, The Netherlands, April 16, 2026 Khondrion has announced a significant clinical milestone with the first patient dosed in...

By cGxPwire Editor
April 17, 2026

Read More

Advertisement

cGxPJobs

Directory